These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19292018)

  • 1. [CardiReset: general medicine and monitoring of cardiovascular risk factors in a whole region].
    Vanuzzo D; Samani F; Canciani L; Paduano R; Pilotto L; Bader G; Mirolo R; Battigelli D; Panfilo M; Fattori MG; Simon G; Zanier L;
    G Ital Cardiol (Rome); 2009 Jan; 10(1):37-43. PubMed ID: 19292018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Initiative" in primary care: survey on hypertension prevalence and definition of cardiovascular risk profile in ASL 3 of Lagonegro (PZ)].
    Damiani G; De Fino M; Federico B; Trani F; Pennelli S; Ricciardi G
    Ann Ig; 2006; 18(2):137-45. PubMed ID: 16649511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: a comparative study with Italian mainland.
    Muntoni S; Atzori L; Mereu R; Manca A; Satta G; Gentilini A; Bianco P; Baule A; Baule GM; Muntoni S
    Eur J Intern Med; 2009 Jul; 20(4):373-7. PubMed ID: 19524177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global cardiovascular risk evaluation in Italy: a cross-sectional survey in general practice.
    Filippi A; Buda S; Brignoli O; Cricelli C; Degli Esposti E
    Ital Heart J; 2004 Mar; 5(3):223-7. PubMed ID: 15119506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A cross-sectional survey to evaluate the cardiovascular risk profile in subjects referred to the Verona-ASL 20 general practitioners].
    Bastarolo D; Battaggia A; Blengio G; Bustacchini S; Celebrano M; Danti G; Flor L; Girotto S; Joppi R; Lombardo G; Mezzalira L; Mirandola M; Panfilo M; Pescarin G; Ruffo P;
    Ital Heart J Suppl; 2005 Jun; 6(6):382-7. PubMed ID: 16013431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors in the Japanese northeastern rural population.
    Ohsawa M; Itai K; Tanno K; Onoda T; Ogawa A; Nakamura M; Kuribayashi T; Yoshida Y; Kawamura K; Sasaki S; Sakata K; Okayama A
    Int J Cardiol; 2009 Nov; 137(3):226-35. PubMed ID: 18707775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular risk factors in Italy: an interpretation with reference to th National Health Plan 1998-2000. Research Group of the Cardiovascular Epidemiologic Observatory].
    Giampaoli S; Vanuzzo D
    G Ital Cardiol; 1999 Dec; 29(12):1463-71. PubMed ID: 10687109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular health in Italy. Ten-year surveillance of cardiovascular diseases and risk factors: Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey 1998-2012.
    Giampaoli S; Palmieri L; Donfrancesco C; Lo Noce C; Pilotto L; Vanuzzo D;
    Eur J Prev Cardiol; 2015 Sep; 22(2 Suppl):9-37. PubMed ID: 26195612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elderly patients in the family doctor's office. Almost every patient has more than one risk factor].
    Einecke D
    MMW Fortschr Med; 2005 Nov; 147(45):43-4, 46. PubMed ID: 16320652
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
    Varis J; Savola H; Vesalainen R; Kantola I
    Blood Press; 2009; 18(1-2):62-7. PubMed ID: 19353413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of cardiometabolic risk factors among young physicians in India.
    Ramachandran A; Snehalatha C; Yamuna A; Murugesan N
    J Assoc Physicians India; 2008 Jan; 56():17-20. PubMed ID: 18472494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factors in the Bedouin population: management and compliance.
    Tamir O; Peleg R; Dreiher J; Abu-Hammad T; Rabia YA; Rashid MA; Eisenberg A; Sibersky D; Kazanovich A; Khalil E; Vardy D; Shvartzman P
    Isr Med Assoc J; 2007 Sep; 9(9):652-5. PubMed ID: 17939626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk factors in Tlemcen (Algeria)].
    Latifa BH; Kaouel M
    Sante; 2007; 17(3):153-8. PubMed ID: 18180216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular risk factors in women in menopause].
    Giampaoli S; Panico S; Meli P; Conti S; Lo Noce C; Pilotto L; Vanuzzo D;
    Ital Heart J Suppl; 2000 Sep; 1(9):1180-7. PubMed ID: 11140287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CHAD program for the control of cardiovascular risk factors in a Jerusalem community: a 24-year retrospect.
    Abramson JH; Gofin J; Hopp C; Schein MH; Naveh P
    Isr J Med Sci; 1994 Jan; 30(1):108-19. PubMed ID: 8138386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for major cardiovascular risk factors among Members of Polish Parliament as a continuation of health marketing for effective cardiovascular prevention in Poland. Warsaw, May 2006.
    Rutkowski M; Zdrojewski T; Bandosz P; Wierucki L; Piwoński J; Piwońska A; Narkiewicz K; Opolski G; Drygas W; Korewicki J; Wyrzykowski B
    Kardiol Pol; 2007 May; 65(5):486-92; discussion 493-4. PubMed ID: 17577845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of dyslipidemia and general ineffectiveness of its treatment in both primary and secondary prevention of coronary heart disease within family medicine framework--results of LIPIDOGRAM 2005--a nationwide epidemiological study. Dyslipidemia in Poland--ineffective treatment.
    Konduracka E; Jóźwiak J; Mastej M; Lukas W; Tykarski A; Szczepaniak-Chicheł L; Piwowarska W
    Przegl Lek; 2008; 65(12):834-7. PubMed ID: 19441674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.